why are you so ridicolous?
DOV has 1.77$ cash per share? That's not their money, that's the money the debenture holders gave them and not they might ask it back, noone knows. Management has been buying stock? They can't during the reorganization due to insider trading restrictions.
But the one thing you posted that I loved more was this:
"on 7 December 2006, DOVP.PK announced that Merck had given up on DOV Patents as a business decision after the poor clinical trial results on radiating leg pain reported this summer. Curiously, DOVP.PK stock went up. A week later we found out why. DOV Pharm announced better patent royalty agreements with Wyeth."
of course you have no idea on what you're talking about and don't even took your time so understand that "trial results on radiating leg pain" was associated with bicifadine results, and that the Merck partnerships was for dov 21,947 and dov 216,303, mostly targeting depression and anxiety disorders.
Kid...